3 days popular7 days popular1 month popular3 months popular

Drug regulations tied to fewer prescriptions of effective gout drug

Well intentioned, but costly and potentially problematic. That’s how researchers describe the end result of a decision by the Food and Drug Administration (FDA) to regulate colchicine, a drug used to treat gout, among other ailments. Fewer patients are actually now taking it, and it has come at a cost to their wallets, says study [...]

Few foods sold in US grocery stores meet FDA sodium requirements

In a CDC study spanning three regions of the United States, researchers found that fewer than half of U.S. grocery-store products in most food categories met Food and Drug Administration (FDA) sodium-per-serving conditions for labeling as a “healthy” food. Researchers analyzed 2009 product sales for US grocery stores from three of the nine U.S. census [...]

New hepatitis C drugs will place strain on health care system, MD Anderson study

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by researchers at The University of Texas MD Anderson Cancer Center. The findings, reported in the Annals of [...]

UF Health researchers investigate effectiveness of a generic heart drug

University of Florida Health researchers are investigating whether a generic form of a common heart medicine used for high blood pressure, heart failure and many other conditions works as well as the brand-name prescription. Through a $2.3 million, three-year grant from the U.S. Food and Drug Administration, UF Health researchers hope to learn if patients [...]

Taking immunosuppressives, anti-cancer drugs may reactivate hepatitis B

Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a summary of report from the Emerging Trends Conference, “Reactivation of Hepatitis B,” and published in Hepatology, a journal of the American Association for the Study of Liver Diseases. Reactivation [...]